Monsanto Demands Retraction for WHOs Glyphosate Cancer ConnectionHeather Callaghan Even though Europe is set to re-approve glyphosate use next year, Monsanto company is outraged at the finding and its publicity. It is using the technique deny, deny, deny and is demanding a retraction. Monsantos aggressive response to the findings might be due to reports of stocks dropping by 1.9% on Monday following the IARC report. Dr. Robb Fraley, Monsantos Chief Technology Officer, who expressed the flabbergast and outrage in a recent statement claims that it flies in the face of decades of comprehensive safety reviews and calls the announcement a cherry-picking of data with an agenda-driven bias. He rests all the weight on regulatory status but doesnt mention that the regulatory agencies rest approval based on company statements. After much hypocritical condemnation of IARC and accusations of causing confusion, Fraley reveals the kicker: IARCs process is not transparent Monsanto really had nearly two decades of a heyday (and stock increases) with glyphosate approval. At first the EPA found a cancer risk based on animal experiments and then changed their tune with a nod of approval since the early 1990s. Ultimately, the yea or nay rests with the EPA who will look at the IARC report as part of their review process, but will no doubt approve glyphosate anyway despite so many alarming independent studies that warn of devastating effects to humans. Just one found glyphosate to be implicated as a breast cancer cause atthe parts per trillion range. Monsantos chief, Hugh Grant like the perfect deflector admitted for the first time that hubris could be responsible for consumer backlash against GMOs and GMO accessories. Not quite Make a product that doesnt kill people and the land then well all sit down and talk about attitudes and perceptions. Dees Illustration Also see: Heather Callaghan is a natural health blogger and food freedom activist. You can see her work atNaturalBlaze.com and selfnewsPost.com. Like at Facebook. Recent posts byHeather Callaghan: 